Nagareyama, Japan

Takashi Tsuji

USPTO Granted Patents = 50 

 

 

Average Co-Inventor Count = 2.4

ph-index = 5

Forward Citations = 148(Granted Patents)


Location History:

  • Nagareyama, JP (2004 - 2018)
  • Chiba, JP (2011 - 2018)
  • Tsukuba, JP (2016 - 2018)
  • Nagano, JP (2008 - 2019)
  • Kyoto, JP (2019)
  • Matsumoto, JP (2009 - 2021)
  • Wako, JP (2021)
  • Tokyo, JP (2010 - 2024)

Company Filing History:


Years Active: 2004-2025

where 'Filed Patents' based on already Granted Patents

50 patents (USPTO):

Title: The Innovations of Takashi Tsuji

Introduction

Takashi Tsuji is a noteworthy inventor based in Nagareyama, Japan, distinguished by his extensive contribution to the field of pharmaceuticals. With an impressive portfolio of 45 patents, Tsuji has played a pivotal role in developing innovative compounds aimed at treating various medical conditions. His work not only reflects his scientific prowess but also highlights the potential of his inventions to impact healthcare positively.

Latest Patents

Among his latest patents, Tsuji has developed novel azole derivatives that act as apelin receptor agonists. This advancement is particularly significant, as it provides a method for treating cardiovascular diseases, diabetes, renal diseases, hypertension, and arteriosclerosis. The invention details a compound represented by a specific formula, crucial for developing therapeutic applications.

Another notable patent involves a biaryl derivative, which consists of a compound or its pharmacologically acceptable salt that exhibits excellent tissue non-specific alkaline phosphatase inhibitory activity. This patented compound is described by a formula that includes a variety of functional groups, all contributing to its therapeutic relevance.

Career Highlights

Takashi Tsuji's career includes positions at prestigious companies such as Fuji Electric Co., Ltd. and Organ Technologies, Inc. His dedication to research and development at these institutions has been instrumental in bringing innovative solutions to the market, particularly in the pharmaceutical sector.

Collaborations

Throughout his career, Tsuji has collaborated with esteemed colleagues, including Akimasa Kinoshita and Kenji Fukuda. These partnerships have fostered an environment of innovation and have contributed to the success of his research endeavors.

Conclusion

In conclusion, Takashi Tsuji's contributions to pharmaceutical innovations through his extensive patent portfolio are noteworthy. His inventions not only advance scientific understanding but also hold the potential to significantly improve patient care across various health conditions. As he continues to push the boundaries of research, Tsuji remains a prominent figure in the field of drug development and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…